Q&A Document to European NfG [Regulatives / Guidelines]

posted by Jaime_R – Barcelona, 2006-08-18 17:54 (6432 d 20:29 ago) – Posting: # 224
Views: 8,036

Hi Helmut,

after browsing through the document, I'm a little bit confused...

Are the rumors of a nostalgic 'Habsburgian' conspiracy with some Hungarian/Spanish/Dutch touch true? ;-)

What makes me wonder is the fact that it took nine drafted versions to proceed from one adopted NfG on BA/BE (1992) to the last one (2001): endless discussions, presentations at international conferences, etc.

The MR-NfG obviously remains 'stuck' at Draft #15 from 1999, and now we have a Q&A document which was (secretly?) prepared by an anonymous 'Therapeutic Subgroup on Pharmacokinetics (EWP-PK)': no drafted versions, no public discussion, etc.

I'm asking myself whether the EWP-PK (with its eight members, again according to rumors...) is representative of the European Regulatority Authorities?

But possibly preparing such a document is just a displacement activity for the real important stuff: two separate guidances for BA and BE!

Regards, Jaime

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
103 visitors (0 registered, 103 guests [including 8 identified bots]).
Forum time: 13:23 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5